Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Schepke
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Concepts & Ideas
Devices
Phenomena
Chemicals & Drugs
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
41
Sauerbruch, Tilman
16
Heller, Jörg
9
Biecker, Erwin
8
Brensing, Karl August
6
Appenrodt, Beate
6
Neef, Markus
5
Schiedermaier, Peter
5
Spengler, Ulrich
5
Trebicka, Jonel
4
Schild, Hans
4
Raab, Peter
4
Rabe, Christian
4
Wolff, Martin
3
Ziske, Carsten
3
Strehl, John
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Schepke (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Appenrodt Beate; Zielinski Julia; Brensing Karl August; Heller Jörg; Sauerbruch Tilman; Schepke Michael
Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis.
European journal of gastroenterology & hepatology 2009;21(12):1428-32.
-
2009: Schepke Michael
Drugs, ligation or both for the prevention of variceal rebleeding?
Gut 2009;58(8):1045-6.
-
2009: Biecker Erwin; Classen Leonie; Sauerbruch Tilman; Schepke Michael
Does therapy of oesophageal varices influences the progression of varices?
European journal of gastroenterology & hepatology 2009;21(7):751-5.
-
2009: Schepke Michael; Biecker Erwin; Appenrodt Beate; Heller Joerg; Sauerbruch Tilman
Coexisting gastric varices should not preclude prophylactic ligation of large esophageal varices in cirrhosis.
Digestion 2009;80(3):165-9.
-
2008: Haenisch Britta; von Kügelgen Ivar; Bönisch Heinz; Göthert Manfred; Sauerbruch Tilman; Schepke Michael; Marklein Günter; Höfling Katja; Schröder Detlev; Molderings Gerhard J
Regulatory mechanisms underlying agmatine homeostasis in humans.
American journal of physiology. Gastrointestinal and liver physiology 2008;295(5):G1104-10.
-
2008: Appenrodt Beate; Wolf Andrea; Grünhage Frank; Trebicka Jonel; Schepke Michael; Rabe Christian; Lammert Frank; Sauerbruch Tilman; Heller J
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(7):1019-25.
-
2008: Schepke Michael; Wiest Reiner; Flacke Sebastian; Heller Jörg; Stoffel-Wagner Birgit; Herold Thomas; Ghauri Masooma; Sauerbruch Tilman
Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
The American journal of gastroenterology 2008;103(5):1152-8.
-
2007: Biecker Erwin; Roth Felix; Heller Jörg; Schild Hans H; Sauerbruch Tilman; Schepke Michael
Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis.
European journal of gastroenterology & hepatology 2007;19(10):846-52.
-
2007: Schepke Michael
Hepatorenal syndrome: current diagnostic and therapeutic concepts.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22 Suppl 8():viii2-viii4.
-
2007: Trebicka Jonel; Hennenberg Martin; Laleman Wim; Shelest Nataliya; Biecker Erwin; Schepke Michael; Nevens Frederik; Sauerbruch Tilman; Heller Jörg
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
Hepatology (Baltimore, Md.) 2007;46(1):242-53.
-
2007: Hennenberg Martin; Trebicka Jonel; Biecker Erwin; Schepke Michael; Sauerbruch Tilman; Heller Jörg
Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
Hepatology (Baltimore, Md.) 2007;45(2):495-506.
-
2006: Willinek W A; Hadizadeh D; von Falkenhausen M; Koscielny A; Wolff M; Schepke M; Schild H H; Strunk H
Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia.
Abdominal imaging 2006;31(6):694-700.
-
2006: Gerhardt Thomas; Milz Sabine; Schepke Michael; Feldmann Georg; Wolff Martin; Sauerbruch Tilman; Dumoulin Franz Ludwig
C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
World journal of gastroenterology : WJG 2006;12(34):5495-500.
-
2006: Schepke Michael; Appenrodt Beate; Heller Jörg; Zielinski Julia; Sauerbruch Tilman
Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(7):834-9.
-
2006: Schepke M
[Primary prevention of variceal bleeding in cirrhosis]
Deutsche medizinische Wochenschrift (1946) 2006;131(22):1269-72.
-
2006: Rabe C; Balta Z; Wüllner U; Heller J; Hammerstingl C; Tiemann K; Sommer T; Schepke M; Fischer H-P; Sauerbruch T
Biliary metal stents and air embolism: a note of caution.
Endoscopy 2006;38(6):648-50.
-
2006: Gorschlüter Marcus; Mey Ulrich; Strehl John; Schepke Michael; Lamberti Christoph; Sauerbruch Tilman; Glasmacher Axel
Cholecystitis in neutropenic patients: retrospective study and systematic review.
Leukemia research 2006;30(5):521-8.
-
2006: Appenrodt Beate; Schepke M; Kuntz-Hehner S; Schmiedel A; Sauerbruch T
A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt.
European journal of gastroenterology & hepatology 2006;18(4):447-9.
-
2006: Link Björn-Christian; Ziske Carsten G; Schepke Michael; Schmidt-Wolf Ingo G H; Sauerbruch Tilman
Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites.
European journal of gastroenterology & hepatology 2006;18(2):181-6.
-
2005: Schepke Michael; Sauerbruch Tilman
Is endoscopic variceal band ligation more effective than propranolol for the prevention of esophageal hemorrhage?
Nature clinical practice. Gastroenterology & hepatology 2005;2(9):396-7.
-
2005: Gorschlüter Marcus; Mey Ulrich; Strehl John; Ziske Carsten; Schepke Michael; Schmidt-Wolf Ingo G H; Sauerbruch Tilman; Glasmacher Axel
Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
European journal of haematology 2005;75(1):1-13.
-
2005: Heller Jörg; Trebicka Jonel; Shiozawa Thomas; Schepke Michael; Neef Markus; Hennenberg Martin; Sauerbruch Tilman
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(3):657-66.
-
2005: Biecker E; Heller J; Appenrodt B; Schepke M; Sauerbruch T
[Gastrointestinal bleeding in portal hypertension in liver cirrhosis]
Zeitschrift für Gastroenterologie 2005;43(1):35-46.
-
2005: Biecker Erwin; Schepke Michael; Sauerbruch Tilman
The role of endoscopy in portal hypertension.
Digestive diseases (Basel, Switzerland) 2005;23(1):11-7.
-
2004: Sauerbruch T; Schepke M
[Variceal hemorrhage: primary and secondary prophylaxis]
Deutsche medizinische Wochenschrift (1946) 2004;129 Suppl 2():S68-70.
-
2004: Schepke Michael; Kleber Gerhard; Nürnberg Dieter; Willert Jörg; Koch Lydia; Veltzke-Schlieker Wilfried; Hellerbrand Claus; Kuth Johannes; Schanz Stefan; Kahl Stefan; Fleig Wolfgang E; Sauerbruch Tilman;
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology (Baltimore, Md.) 2004;40(1):65-72.
-
2004: Schepke Michael
Can we predict hepatocellular carcinoma by endoscopy?
Digestion 2004;70(4):231-2.
-
2003: Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
European journal of clinical investigation 2003;33(11):1006-12.
-
2003: Strehl J; Schepke M; Wardelmann E; Caselmann W H; Sauerbruch T
[Chronic diarrhea in a 43-year-old patient]
Der Internist 2003;44(5):626-30.
-
2003: Schepke Michael; Roth Felix; Fimmers Rolf; Brensing Karl August; Sudhop Thomas; Schild Hans H; Sauerbruch Tilman
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
The American journal of gastroenterology 2003;98(5):1167-74.
-
2003: Neef M; Biecker E; Heller J; Schepke M; Nischalke H D; Wolff M; Spengler U; Reichen J; Sauerbruch T
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries.
European journal of clinical investigation 2003;33(3):249-55.
-
2003: Schepke Michael; Roth Felix; Koch Lydia; Heller Jörg; Rabe Christian; Brensing Karl-August; Schiedermaier Peter; Schild Hans H; Sauerbruch Tilman
Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding.
Digestion 2003;67(3):146-53.
-
2002: Heller Jörg; Schepke Michael; Neef Markus; Woitas Rainer; Rabe Christian; Sauerbruch Tilman
Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.
Journal of hepatology 2002;37(6):767-72.
-
2002: Schaible R; Textor J; Schepke M; Wolff M; Schild H; Kreft B
[MRI in cavernous transformation of the portal vein: secondary biliary abnormalities and portoportal collaterals]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2002;174(11):1408-14.
-
2002: Brensing K A; Hörsch M; Textor J; Schiedermaier P; Raab P; Schepke M; Strunk H; Schild H; Sauerbruch T
Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt.
Scandinavian journal of gastroenterology 2002;37(9):1070-6.
-
2002: Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Endoscopy 2002;34(7):519-23.
-
2002: Brensing Karl August; Raab Peter; Textor Jochen; Görich Johannes; Schiedermaier Peter; Strunk Holger; Paar Dieter; Schepke Michael; Sudhop Thomas; Spengler Ulrich; Schild Hans; Sauerbruch Tilman
Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis.
European journal of gastroenterology & hepatology 2002;14(7):723-31.
-
2002: Gülberg V; Schepke M; Geigenberger G; Holl J; Brensing K A; Waggershauser T; Reiser M; Schild H H; Sauerbruch T; Gerbes A L
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
Scandinavian journal of gastroenterology 2002;37(3):338-43.
-
2001: Schepke M; Heller J; Paschke S; Thomas J; Wolff M; Neef M; Malago M; Molderings G J; Spengler U; Sauerbruch T
Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism.
Hepatology (Baltimore, Md.) 2001;34(5):884-8.
-
2001: Schepke M; Reichel C; Ziske C; Spengler U; Caselmann W H; Sauerbruch T
[Liver cirrhosis--2: Complications and treatment]
Deutsche medizinische Wochenschrift (1946) 2001;126(36):978-81; quiz 982-4.
-
2001: Schepke M; Sauerbruch T
[Liver cirrhosis--case report]
Deutsche medizinische Wochenschrift (1946) 2001;126(36):975.
-
2001: Schepke M; Werner E; Biecker E; Schiedermaier P; Heller J; Neef M; Stoffel-Wagner B; Hofer U; Caselmann W H; Sauerbruch T
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Gastroenterology 2001;121(2):389-95.
-
2001: Schepke M; Sauerbruch T
Transjugular portosystemic stent shunt in treatment of liver diseases.
World journal of gastroenterology : WJG 2001;7(2):170-4.
-
2000: Schepke M; Raab P; Hoppe A; Schiedermaier P; Brensing K A; Sauerbruch T
Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis.
The American journal of gastroenterology 2000;95(10):2905-9.
-
1999: Schepke M; Raab P; Hoppe A; Brensing K; Paar D; Potyka U; Sauerbruch T
Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.
Alimentary pharmacology & therapeutics 1999;13(11):1451-8.
-
1999: Heller J; Schepke M; Gehnen N; Molderings G J; Müller A; Erhard J; Spengler U; Sauerbruch T
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis.
Gastroenterology 1999;116(2):387-93.
-
1997: Terjung B; Paar W D; Schepke M; Klehr H U; Hufnagel A; Sauerbruch T
[The Churg-Strauss syndrome with cerebral seizures and terminal kidney failure]
Deutsche medizinische Wochenschrift (1946) 1997;122(27):853-8.
-
1993: Klingmüller D; Schepke M; Enzweiler C; Bidlingmaier F
Hormonal responses to the new potent GnRH antagonist Cetrorelix.
Acta endocrinologica 1993;128(1):15-8.
Sign-in to see more
